|
|
Tanzania
|
TAN 22 V 0513
|
Gardasil
|
Aluminium hydroxy-phosphate sulfate 225 mcg/ml,Human Papillomavirus type 11 L1 Protein 40 mcg/0.5ml,Human Papillomavirus type 16 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 18 L1 Protein 20 mcg/0.5ml,Human Papillomavirus type 6 L1 Protein 20 mcg/0.5ml,L-Histidine 0.78 ml/100ml,Polysorbate-80 50 mcg/ml,Sodium Borate 35 mcg/ml,Sodium Chloride 225 mcg/ml,Water for injections qs
|
Baxter Pharmaceutical Solutions LLC
|
Registered/Compliant
|
Details →
|
|
|
Zimbabwe
|
2014/18.2/4958
|
GARDASIL
|
HUMAN PAPILLOMA VIRUS VACCINE TYPES 6, 11, 16, 18
|
MERCK SHARP & DOHME BV, B. V. WAARDERWEG 39, HAARLEM, NETHERLANDS; EUROFINS LANCASTER LABORATORIES INC, 2525 NEW HOLLAND PIKE, LANCASTER, U.S.A.; BAXTER PHARMACEUTICAL SOLUTIONS LLC, 927 SOUTH CURRY PIKE, INDIANA, BLOOMINGTON, U.S.A.; PATHEON ITALIA S.P.A , VIALE G.B STUCCHI, 110, MONZA, ITALY; MERCK SHARP & DOHME LLC, 770 SUMNEYTOWN PIKE, PENNSYLVANIA, .., U.S.A.;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|